THOUSAND OAKS, Calif.–(EMWNews)–Amgen (NASDAQ:AMGN) today announced that it plans to report its second
quarter financial results on Monday, July 28, 2008 after the close of
the financial markets. The announcement will be followed by a conference
call with the investment community at 2 p.m. Pacific Time. Participating
in the call from Amgen will be Kevin Sharer, chairman and chief
executive officer, and other members of Amgen’s
senior management team.
Live audio of the conference call will be simultaneously broadcast over
the Internet and will be available to members of the news media,
investors and the general public. The conference call, including the
question and answer session, is expected to last approximately one hour.
The webcast of the conference, as with other selected presentations
regarding developments in Amgen’s business
given by management at certain investor and medical conferences, can be
found on Amgen’s Web site, www.amgen.com,
under Investors. Information regarding presentation times, webcast
availability, and webcast links are noted on Amgen’s
Investor Relations Events Calendar. The webcast will be archived and
available for replay 72 hours after the event.
Amgen discovers, develops, manufactures and delivers innovative human
therapeutics. A biotechnology pioneer since 1980, Amgen was one of the
first companies to realize the new science’s
promise by bringing safe and effective medicines from lab, to
manufacturing plant, to patient. Amgen therapeutics have changed the
practice of medicine, helping millions of people around the world in the
fight against cancer, kidney disease, rheumatoid arthritis, and other
serious illnesses. With a deep and broad pipeline of potential new
medicines, Amgen remains committed to advancing science to dramatically
improve people’s lives. To learn more about
our pioneering science and our vital medicines, visit www.amgen.com.
Major Newsire & Press Release Distribution with Basic Starting at only $19 and Complete OTCBB / Financial Distribution only $89